Development Level

Tbio 20 | 11,651
Tchem 3 | 1,388
Tclin 1 | 612

IMPC Phenotype

decreased leukocyte cell numbe... 2 | 73
embryonic lethality prior to t... 2 | 278
preweaning lethality, complete... 2 | 979
abnormal bone structure 1 | 187
abnormal cranium morphology 1 | 36
abnormal embryo size 1 | 220
abnormal pericardium morpholog... 1 | 26
abnormal retina morphology 1 | 71
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 53
decreased circulating serum al... 1 | 82
decreased mean corpuscular hem... 1 | 50
decreased spleen weight 1 | 10
decreased vertical activity 1 | 208
edema 1 | 59
embryonic growth retardation 1 | 106
embryonic lethality prior to o... 1 | 239
enlarged kidney 1 | 14
hypoactivity 1 | 132
increased circulating HDL chol... 1 | 80
increased circulating LDL chol... 1 | 13
increased circulating alkaline... 1 | 122
increased heart left ventricle... 1 | 4
increased neutrophil cell numb... 1 | 46
increased spleen weight 1 | 10
preweaning lethality, incomple... 1 | 499
short tibia 1 | 97

Disease

Carcinoma 18 | 11,493
glioblastoma 16 | 5,792
ovarian cancer 16 | 8,520
medulloblastoma, large-cell 14 | 6,241
osteosarcoma 13 | 7,950
Cancer 10 | 2,499
atypical teratoid / rhabdoid tumor 10 | 5,112
psoriasis 10 | 6,694
lung cancer 9 | 4,740
oligodendroglioma 9 | 2,850
adult high grade glioma 8 | 3,801
astrocytic glioma 8 | 2,597
malignant mesothelioma 8 | 3,232
Astrocytoma, Pilocytic 7 | 3,081
Pick disease 7 | 1,894
group 3 medulloblastoma 7 | 4,104
primitive neuroectodermal tumor 7 | 3,035
ependymoma 6 | 4,679
interstitial cystitis 6 | 2,312
pituitary cancer 6 | 1,972
subependymal giant cell astrocytoma 6 | 2,287
Kidney cancer 5 | 2,613
invasive ductal carcinoma 5 | 2,951
non-small cell lung cancer 5 | 2,890
Breast cancer 4 | 3,578
Rheumatoid arthritis 4 | 1,191
acute quadriplegic myopathy 4 | 1,158
adrenocortical carcinoma 4 | 1,428
breast carcinoma 4 | 1,638
pancreatic cancer 4 | 2,398
pediatric high grade glioma 4 | 1,064
primary pancreatic ductal adenocarcinoma 4 | 1,109
Chronic Lymphocytic Leukemia 3 | 262
Cleft Palate 3 | 271
Melanoma 3 | 711
Multiple Sclerosis 3 | 540
Multiple myeloma 3 | 1,332
Prostatic Neoplasms 3 | 495
Schizophrenia 3 | 1,160
acute myeloid leukemia 3 | 783
hepatocellular carcinoma 3 | 547
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
juvenile dermatomyositis 3 | 1,187
lung carcinoma 3 | 2,843
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
primary Sjogren syndrome 3 | 735
spina bifida 3 | 1,074
ulcerative colitis 3 | 1,819
Adams-Oliver syndrome 2 | 15
Adenocarcinoma 2 | 122
Alcoholic Intoxication, Chronic 2 | 289
Anemia 2 | 365
Animal Mammary Neoplasms 2 | 136
Autosomal recessive predisposition 2 | 1,442
Breast Neoplasms 2 | 445
Carcinoma, Hepatocellular 2 | 228
Cholangiocarcinoma 2 | 35
Colonic Neoplasms 2 | 142
Craniofacial Abnormalities 2 | 151
Dermatitis 2 | 157
Disease Progression 2 | 136
Endometriosis 2 | 540
Immune system cancer 2 | 140
Liver carcinoma 2 | 240
Lung Neoplasms 2 | 232
Major Depressive Disorder 2 | 301
Mammary Neoplasms 2 | 425
Mammary Neoplasms, Animal 2 | 136
Mammary Neoplasms, Experimental 2 | 154
Myofibrillar myopathy 1 2 | 6
Myofibrillar myopathy 3 2 | 5
Neoplasm Invasiveness 2 | 161
Neoplasm Metastasis 2 | 168
Pick's disease 2 | 15
Skin cancer 2 | 469
Spinocerebellar ataxia type 2 2 | 23
Unipolar Depression 2 | 250
aldosterone-producing adenoma 2 | 665
astrocytoma 2 | 1,146
dermatomyositis 2 | 966
ductal carcinoma in situ 2 | 1,745
esophageal adenocarcinoma 2 | 737
fibroadenoma 2 | 559
gastric cancer 2 | 459
gastric carcinoma 2 | 807
group 4 medulloblastoma 2 | 1,855
lung adenocarcinoma 2 | 2,716
non primary Sjogren syndrome sicca 2 | 891
progressive supranuclear palsy 2 | 676
tuberculosis 2 | 2,010
tuberculosis and treatment for 3 months 2 | 179
Brain cancer 1 | 30
Chloracne 1 | 32
Gastrointestinal system disease 1 | 54
Head and Neck Neoplasms 1 | 26
Papilloma 1 | 44
Precancerous Conditions 1 | 80
Pulmonary Fibrosis 1 | 106

Tissue

Blood and immune system 24 | 16,909
Digestive Tract 24 | 17,369
Endocrine System 24 | 18,159
Female tissues 24 | 17,400
Male tissues 24 | 17,142
Nervous System 24 | 16,725
Respiratory system 24 | 16,393
Skin and soft tissues 24 | 17,230
Urinary Tract 24 | 16,678
Cardiovascular System 23 | 15,192
Liver and Pancreas 23 | 16,750

Target Family

Non-IDG 16 | 12,091
Enzyme 7 | 4,145
Kinase 1 | 634

Reactome Pathway

EGFR downregulation 24 | 24
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Epsin-1 EPN1 Tbio Non-IDG -1.52389 32.5 163
Endophilin-A1 SH3GL2 Tbio Non-IDG -1.79540 59.9 248
Endophilin-A3 SH3GL3 Tbio Non-IDG -1.03962 9.87 97
Pro-epidermal growth factor EGF Tbio Non-IDG -3.75933 4903.2 978
Protein sprouty homolog 2 SPRY2 Tbio Non-IDG -1.90829 87.6 217
Protein sprouty homolog 1 SPRY1 Tbio Non-IDG -2.19105 141.2 190
Epidermal growth factor receptor substrate 15 EPS15 Tbio Non-IDG -2.28374 174.5 164
Growth factor receptor-bound protein 2 GRB2 Tchem Non-IDG -3.02404 981.4 501
Tyrosine-protein phosphatase non-receptor type 12 PTPN12 Tchem Enzyme -1.81716 68.8 125
Hepatocyte growth factor-regulated tyrosine kinase substrate HGS Tbio Enzyme -2.76643 560.1 379